Allergan Sales, LLC et al v. Breckenridge Pharmaceutical, Inc. > Summary
Court Case Number 1:20-cv-00199
Filing Date Feb 10, 2020
Termination Date Nov 18, 2020
Court Delaware District Court
Status Judgment - Judgment on Consent
JudgesMitchell S. Goldberg
Defendant
Plaintiff Attorneys
11Allergan
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Allergan
Attorney Name: Jeremy A. Tigan
Morris Nichols Arsht & Tunnell
allergan pharmaceuticals international
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
allergan pharmaceuticals international
Attorney Name: Jeremy A. Tigan
Morris Nichols Arsht & Tunnell
ALLERGAN USA, INC.
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
ALLERGAN USA, INC.
Attorney Name: Jeremy A. Tigan
Morris Nichols Arsht & Tunnell
Amgen
Attorney Name: Charles E. Lipsey
Finnegan, Henderson, Farabow, Garrett & Dunner
Amgen
Attorney Name: Howard W. Levine
Finnegan, Henderson, Farabow, Garrett & Dunner
Amgen
Attorney Name: Sanya Sukduang
Finnegan, Henderson, Farabow, Garrett & Dunner
Amgen
Attorney Name: Jonathan R. Davies
Finnegan, Henderson, Farabow, Garrett & Dunner
Amgen
Attorney Name: Matthew J. Luneack
Finnegan, Henderson, Farabow, Garrett & Dunner
Defendant Attorneys
Breckenridge Pharmaceutical
Attorney Name: Stephen B. Brauerman
Bayard, P.A.
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 05763476 | Sublingual or buccal pharmaceutical composition | Jun 9, 1998 |
